Gene: AGAP5
Official Full Name: ArfGAP with GTPase domain, ankyrin repeat and PH domain 5provided by HGNC
Gene Summary: Predicted to enable GTPase activator activity and GTPase activity. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19953 | AGAP5 Knockout cell line (HeLa) | Human | AGAP5 | 1:3~1:6 | Negative | Online Inquiry |
KO19954 | AGAP5 Knockout cell line (HCT 116) | Human | AGAP5 | 1:2~1:4 | Negative | Online Inquiry |
KO19955 | AGAP5 Knockout cell line (HEK293) | Human | AGAP5 | 1:3~1:6 | Negative | Online Inquiry |
KO19956 | AGAP5 Knockout cell line (A549) | Human | AGAP5 | 1:3~1:4 | Negative | Online Inquiry |
AGAP5 Gene Knockout Cell Lines are engineered cell lines where the AGAP5 gene has been specifically targeted and disrupted, leading to the loss of its normal function. This innovative tool is instrumental in studying the biological roles of AGAP5, a member of the ArfGAP family involved in various cellular processes, including endocytosis, vesicle trafficking, and cell signaling pathways. By creating these knockout models, researchers can dissect the effects of AGAP5 loss on cellular activities and gain insights into its implication in disease states, particularly in cancer and neurodegenerative disorders.
The primary mechanism of AGAP5 Gene Knockout Cell Lines hinges on CRISPR/Cas9 technology, which allows precise editing of the genome. Upon successful integration of the CRISPR elements, AGAP5 expression is abrogated, facilitating controlled studies of downstream effects and compensatory mechanisms in cellular physiology. This targeted approach enables scientists to elucidate the nuanced roles of AGAP5 without the confounding effects seen in wild-type cells.
In research and clinical applications, these knockout cell lines serve as a crucial platform for drug discovery and development, particularly in screening compounds that may alter AGAP5-related pathways. Furthermore, the ability to model specific pathologies contributes significantly to understanding the molecular underpinnings of diseases involving AGAP5 dysfunction.
Compared to traditional methods that often involve overexpression or non-specific knockdown strategies, our AGAP5 Gene Knockout Cell Lines offer unparalleled specificity and reliability. This reduces background noise in experiments, resulting in clearer and more interpretable data. Additionally, with customizable options available, researchers can tailor their studies to investigate specific hypotheses effectively.
For researchers and clinicians focused on advancing our understanding of cellular mechanisms and developing novel therapeutic strategies, AGAP5 Gene Knockout Cell Lines represent a valuable asset in their toolkit. Our commitment to high-quality biological products, supported by extensive expertise in gene editing technologies, ensures that you receive cutting-edge solutions tailored to your research needs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.